GC
BIOC

Globeflex Capital’s Biocept, Inc. BIOC Stock Holding History

Globeflex Capital’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,786
Closed -$215K – 543
2022
Q3 		$215K Hold
7,786
– – 0.04% 345
2022
Q2 		$220K Hold
7,786
– – 0.05% 313
2022
Q1 		$542K Hold
7,786
– – 0.11% 221
2021
Q4 		$846K Sell
7,786
-2,916
-27% -$336K 0.17% 184
2021
Q3 		$1.29M Buy
+10,702
New +$1.25M 0.28% 109

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TMWM
Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

Globeflex Capital's BIOC Position: Q4 2022 in Review

Globeflex Capital sold out of Biocept, Inc. (BIOC) in Q4 2022, closing a stake of 7,786 shares — an estimated $215K sold.

Globeflex Capital first reported a position in BIOC in Q3 2021 and held it in 5 quarters. The position peaked at $1.29M in Q3 2021. 25 funds tracked by Wall St. Rank hold BIOC as of Q4 2022.

  • Globeflex Capital reported no remaining Biocept, Inc. position as of Q4 2022 after selling out during the quarter.
  • Globeflex Capital sold 7,786 Biocept, Inc. shares in Q4 2022, an estimated $215K.
  • Globeflex Capital first reported a position in Biocept, Inc. in Q3 2021 and held it in 5 quarters.
  • Globeflex Capital's Biocept, Inc. position peaked at $1.29M in Q3 2021.
  • 25 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2022.

Based on Globeflex Capital's 13F filing for Q4 2022, filed 10 Feb 2023.